KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to -$2.5 billion.

  • Thermo Fisher Scientific's Net Cash Flow rose 3.31% to -$2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 billion, marking a year-over-year decrease of 57.19%. This contributed to the annual value of -$4.0 billion for FY2024, which is 1007.82% down from last year.
  • Thermo Fisher Scientific's Net Cash Flow amounted to -$2.5 billion in Q3 2025, which was down 2,196.67% from $120.0 million recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Net Cash Flow peaked at $5.4 billion during Q4 2022, and registered a low of -$7.8 billion during Q4 2021.
  • Its 3-year average for Net Cash Flow is -$602.4 million, with a median of -$356.0 million in 2024.
  • Per our database at Business Quant, Thermo Fisher Scientific's Net Cash Flow plummeted by 781.12% in 2021 and then soared by 543.45% in 2024.
  • Thermo Fisher Scientific's Net Cash Flow (Quarterly) stood at -$7.8 billion in 2021, then skyrocketed by 168.91% to $5.4 billion in 2022, then tumbled by 64.15% to $1.9 billion in 2023, then crashed by 118.55% to -$356.0 million in 2024, then grew by 3.31% to -$2.5 billion in 2025.
  • Its Net Cash Flow stands at -$2.5 billion for Q3 2025, versus $120.0 million for Q2 2025 and $94.0 million for Q1 2025.